Literature DB >> 9350408

Comparison of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients.

D Z Bliss1, S Johnson, C R Clabots, K Savik, D N Gerding.   

Abstract

The effectiveness of cycloserine-cefoxitin-fructose agar (CCFA) and taurocholate-CCFA (TCCFA) in isolating Clostridium difficile from swabs of the rectum or stools from 184 hospitalized patients who were monitored weekly and when they had diarrhea was compared. The number of surveillance time points ranged from two to eight per patient over a period of 4 to 34 days per patient, totalling 621 comparisons of the media. C. difficile was isolated more frequently by TCCFA than CCFA at seven of eight surveillance points, a significant trend (O'Brien test, p = 0.002). This difference reached statistical significance at the second surveillance time point when the prevalence of C. difficile was sufficiently high. At the second surveillance point, C. difficle was isolated only by TCCFA in 7 of 184 comparisons of the media, only by CCFA in none of the comparisons, and by both media in 19 comparisons (p = 0.016). C. difficle was first isolated at an earlier surveillance time point on TCCFA in 11 of 36 patients and on CCFA first only once (p = 0.005). Use of TCCFA media increased the rapidity and sensitivity of culture for C. difficle when doing patient surveillance but did not increase sensitivity when diagnosing patients with diarrhea.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350408     DOI: 10.1016/s0732-8893(97)00113-2

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  16 in total

1.  Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection.

Authors:  Alexa R Weingarden; Chi Chen; Ningning Zhang; Carolyn T Graiziger; Peter I Dosa; Clifford J Steer; Megan K Shaughnessy; James R Johnson; Michael J Sadowsky; Alexander Khoruts
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

2.  Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions.

Authors:  Luis G Arroyo; Joyce Rousseau; Barbara M Willey; Don E Low; Henry Staempfli; Allison McGeer; J Scott Weese
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.

Authors:  Joseph A Sorg; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

4.  Evaluation of a new automated homogeneous PCR assay, GenomEra C. difficile, for rapid detection of Toxigenic Clostridium difficile in fecal specimens.

Authors:  Jari J Hirvonen; Silja Mentula; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

Review 5.  Germinants and Their Receptors in Clostridia.

Authors:  Disha Bhattacharjee; Kathleen N McAllister; Joseph A Sorg
Journal:  J Bacteriol       Date:  2016-09-22       Impact factor: 3.490

Review 6.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

7.  Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours.

Authors:  John D Perry; Kerry Asir; Diane Halimi; Sylvain Orenga; Joanne Dale; Michelle Payne; Ruth Carlton; Jim Evans; F Kate Gould
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

Review 8.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens.

Authors:  Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Anaerobe       Date:  2012-12-13       Impact factor: 3.331

10.  MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation.

Authors:  Linda D Bobo; Rana E El Feghaly; Yee-Shiuan Chen; Erik R Dubberke; Zhuolin Han; Alexandra H Baker; Jinmei Li; Carey-Ann D Burnham; David B Haslam
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.